|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61K 31/137 | |||
| A61K 31/485 | |||
| A61K 9/20 |
| (11) | Number of the document | 2061448 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07795652.2 |
| Date of filing the European patent application | 2007-05-31 | |
| (97) | Date of publication of the European application | 2009-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/013030 |
| Date | 2007-05-31 |
| (87) | Number | WO 2007/145863 |
| Date | 2007-12-21 |
| (30) | Number | Date | Country code |
| 811251 P | 2006-06-05 | US | |
| 841114 P | 2006-08-29 | US |
| (72) |
MCKINNEY, Anthony A., US
TOLLEFSON, Gary D., US
SOLTERO, Richard, US
DUNZO, Thea Elise, US
|
| (73) |
Nalpropion Pharmaceuticals, Inc.,
10 North Park Place, Suite 201, Morristown, NJ 07960,
US
|
| (54) | SUSTAINED RELEASE FORMULATION OF NALTREXONE |
| SUSTAINED RELEASE FORMULATION OF NALTREXONE |